Conclusion
death, early‐stage breast cancer
RECURRENT CANCER, BREAST CANCER
We have shown that immunohistochemical assessment of WRAP53 protein using C1‐antibody is prognostic in early‐stage breast cancer, as low nuclear levels were associated with a higher incidence of locally recurrent cancer and death from breast cancer. Low levels of 